Hefei Xingmou Biotechnology Co.
Latest round
- Series A
Last raised
- Sep 2025
Total raised
- Undisclosed
Investors
- 3
About Hefei Xingmou Biotechnology Co.
, Ltd. operates as a medical company that focuses on gene editing and ophthalmic disease gene therapy services. It covers an area of 1600 square meters, with 30 employees. The founding team are professors and doctors from the Chinese Academy of Sciences and the Chinese University of Science and Technology., Ltd., Ltd.'s main business is the development of ophthalmic gene therapy drugs with AAV vectors. Its core product is RGX-314 for the treatment of wet macular degeneration ophthalmic disease. It has technology platforms such as AAV Dual and Multi-Antibody Platform, AAV Viral Coat Screening Technology Platform, and Gene Editing Technology Platform. The company generates revenue by selling ophthalmic gene therapy drugs.
Who invested in Hefei Xingmou Biotechnology Co.
3 investors across 2 rounds
See all investors in Hefei Xingmou Biotechnology Co.
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Questions about Hefei Xingmou Biotechnology Co.
Who invested in Hefei Xingmou Biotechnology Co.?
Hefei Xingmou Biotechnology Co. has 3 investors on record across 2 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Hefei Xingmou Biotechnology Co. raised?
Hefei Xingmou Biotechnology Co. has raised 2 venture rounds. Sign up free to see how much each round raised and the total.
When did Hefei Xingmou Biotechnology Co. last raise money?
Hefei Xingmou Biotechnology Co.'s most recent round on record is a Series A, in Sep 2025.
What does Hefei Xingmou Biotechnology Co. do?
Hefei Xingmou Biotechnology Co. is a biotechnology company.
Where is Hefei Xingmou Biotechnology Co. headquartered?
Hefei Xingmou Biotechnology Co. is headquartered in Hefei, China.
Which VCs invest in companies like Hefei Xingmou Biotechnology Co.?
Among active investors with capital left to deploy, Shanghai State-owned Capital Investment Leading Fund, Hui Hua Fund, Yufu Capital and ICBC Capital Management back biotechnology companies at Hefei Xingmou Biotechnology Co.'s stage. Their profiles are linked below.
VCs backing biotechnology startups at Series A
Raising like Hefei Xingmou Biotechnology Co.? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.